STunning in Acute Myocardial Infarction - BAS
ConditionMyocardial Infarct
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorVastra Gotaland Region
About this trial
The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)
Eligibility criteria
Qualifiers
Patients with STEMI who undergo primary PCI within 6 hours of symptom onset (Excluding prodromal symptoms)
Informed consent
Disqualifiers
Killip class ≥ 3
Chronic kidney disease with GFR < 25 ml/min/1.73 m2
Pre-existing non-reversible cardiac dysfunction or heart failure
Current treatment with any beta blocker, RAAS inhibitor or SGLT2 inhibitor
Trial design
Treatments tested in this trial
- Bisoprolol Oral Tablet
- Ramipril Oral Product
- Dapagliflozin Oral Product
Treatment groups
120 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov